EUVIMEDEUVIMED entdecken
Crossref

Targeted Rheumatoid Arthritis Therapy Using a Smart Nitric Oxide‐Responsive JAK Inhibition

Yeonju Boo, Sangmin Lee, Seohee Lee, Yeong Mi Lee, Won Jong Kim iD

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.202501603 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Yeonju Boo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Pohang University of Science and Technology (POSTECH), 77 Cheongam-Ro, Nam-Gu, Pohang, Gyeongbuk, 37673, Republic of Korea. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Nitric Oxide, Janus Kinase Inhibitors, Janus Kinases. Die Arbeit nennt 49 Literaturangaben. Gefördert von: National Research Foundation of Korea, Korea Institute for Advanced Study.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis (RA) is a chronic autoimmune disease marked by persistent synovial inflammation, which leads to cartilage degradation and bone erosion. While Janus kinase (JAK) inhibitors, such as Tofacitinib (Tofa), have shown clinical efficacy in RA treatment, their broad immunosuppressive effects increase the risk of systemic toxicity. To address this challenge, NOR‐Tofa, a Nitric oxide (NO)‐responsive JAK inhibitor conjugate, designed for selective activation in inflamed joints are developed. NOR‐Tofa incorporates an o ‐phenylenediamine ( o‐ PD) moiety, allowing for NO‐mediated drug release at inflammation sites. Structural characterization confirmed the successful synthesis and NO‐responsiveness of NOR‐Tofa, which exhibited potent JAK inhibition upon activation. In vitro studies using LPS‐stimulated macrophages demonstrated that NOR‐Tofa effectively suppressed JAK‐STAT signaling and reduced the expression of pro‐inflammatory cytokines. In vivo, a collagen‐induced arthritis (CIA) mouse model revealed that NOR‐Tofa treatment significantly alleviated arthritis symptoms and preserved joint structure, with dose‐dependent therapeutic efficacy. Pharmacokinetic analysis indicated that NOR‐Tofa minimized systemic exposure to tofacitinib while selectively activating in inflamed joints, thereby reducing off‐target effects. Moreover, hematological and acute toxicity assessments confirmed the improved safety profile of NOR‐Tofa compared to Tofacitinib. These findings establish NO‐responsive drug activation as a promising strategy for RA treatment, offering a more targeted and safer alternative to conventional JAK inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidNitric OxideJanus Kinase InhibitorsJanus KinasesAnimalsMiceArthritis, ExperimentalPiperidinesPyrimidinesRAW 264.7 CellsHumansSignal TransductionMice, Inbred DBAMaleMacrophages

Stichwörter der Autor:innen

JAK‐STAT signalinganti‐inflammatory therapynitric oxiderheumatoid arthritisstimuli‐responsive materials

Substanzen

Nitric OxideJanus Kinase InhibitorstofacitinibJanus KinasesPiperidinesPyrimidines

Autor:innen und Institutionen

  • Department of Chemistry, Pohang University of Science and Technology (POSTECH), 77 Cheongam-Ro, Nam-Gu, Pohang, Gyeongbuk, 37673, Republic of Korea.
  • OmniaMed Co, Ltd., Pohang, 37673, Republic of Korea.

ORCID-Profile: Won Jong Kim

Förderung

  • National Research Foundation of Korea
  • Korea Institute for Advanced Study

Zitieren

APA

Boo, Y., Lee, S., Lee, S., Lee, Y. M., & Kim, W. J. (2026). Targeted Rheumatoid Arthritis Therapy Using a Smart Nitric Oxide‐Responsive JAK Inhibition. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202501603

Vancouver

Boo Y, Lee S, Lee S, Lee YM, Kim WJ. Targeted Rheumatoid Arthritis Therapy Using a Smart Nitric Oxide‐Responsive JAK Inhibition. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202501603

BibTeX
@article{Boo2026,
  author = {Boo, Yeonju and Lee, Sangmin and Lee, Seohee and Lee, Yeong Mi and Kim, Won Jong},
  title = {Targeted Rheumatoid Arthritis Therapy Using a Smart Nitric Oxide‐Responsive JAK Inhibition},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.202501603}
}
Kostenlos starten →